Vanessa Rivera-Amill to Vaccination
This is a "connection" page, showing publications Vanessa Rivera-Amill has written about Vaccination.
Connection Strength
0.177
-
Madewell ZJ, Graff NE, Lopez VK, Rodriguez DM, Wong JM, Maniatis P, Medina FA, Mu?oz JL, Briggs-Hagen M, Adams LE, Rivera-Amill V, Paz-Bailey G, Major CG. Longitudinal analysis of SARS-CoV-2 IgG antibody durability in Puerto Rico. Sci Rep. 2024 12 28; 14(1):30743.
Score: 0.048
-
Medina FA, Vila F, Adams LE, Cardona J, Carrion J, Lamirande E, Acosta LN, De Le?n-Rodr?guez CM, Beltran M, Grau D, Rivera-Amill V, Balmaseda A, Harris E, Madewell ZJ, Waterman SH, Paz-Bailey G, Whitehead S, Mu?oz-Jord?n JL. Comparison of the sensitivity and specificity of commercial anti-dengue virus IgG tests to identify persons eligible for dengue vaccination. J Clin Microbiol. 2024 Oct 16; 62(10):e0059324.
Score: 0.047
-
Rodriguez DM, Major CG, S?nchez-Gonz?lez L, Jones E, Delorey MJ, Alonso C, Rivera-Amill V, Paz-Bailey G, Adams LE. Dengue vaccine acceptability before and after the availability of COVID-19 vaccines in Puerto Rico. Vaccine. 2023 06 01; 41(24):3627-3635.
Score: 0.043
-
S?nchez-Gonz?lez L, Major CG, Rodriguez DM, Balajee A, Ryff KR, Lorenzi O, Linares M, Adams LE, Rivera-Amill V, Rolfes M, Paz-Bailey G. COVID-19 Vaccination Intention in a Community Cohort in Ponce, Puerto Rico. Am J Trop Med Hyg. 2022 08 17; 107(2):268-277.
Score: 0.040